Cepheid’s Post

I believe in innovation. I believe in investor ROI. I believe in non-profit and taxpayer ROI. I believe in the importance of access to life-changing technologies to the world's poor. There is a world in which these beliefs are not mutually exclusive, can co-exist, and can all be realized. Danaher Corporation owns the incredible #geneXpert technology developed by Cepheid capable of quickly and accurately diagnosing #tuberculosis but the disposable cost is out of reach for many of healthcare providers in the world's poorest countries where people are still dying from this entirely treatable disease from lack of diagnosis. Danaher Life Sciences could significantly lower the consumable cost for these countries (making it exponentially more available), still make a profit, and save tens of thousands of lives. If there is another side to this story which explains why this is not possible or why this is more complex than deciding to do the right things, please post in the comments below. Otherwise please consider empowering this message however you can. #tbtests https://lnkd.in/gY-rwYCq PIH Health Danaher Corporation Danaher Life Sciences Cepheid Bill & Melinda Gates Foundation

Hello Danaher Life Sciences (and Danaher Corporation) my old friend... it's time to talk to you again. Yes, it's been only one day but I learned today that you're silencing your employees. People are calling for you to make more affordable tests and your response is to silence them. Just let that sink in. Who does that? How can you expect to retain and recruit people like that? How much is that going to cost you? Maybe you can do the maths and realise that it'll cost you less than making these tests more affordable. I'll come do the maths for you if you want ;) Until next time. #peoplebeforeprofits

𝗧𝗵𝗲 𝗱𝗲𝗺𝗮𝗻𝗱 𝗳𝗼𝗿 𝗿𝗲𝗹𝗶𝗮𝗯𝗹𝗲, 𝗮𝗰𝗰𝘂𝗿𝗮𝘁𝗲 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲𝘀 𝘁𝗼 𝗿𝗶𝘀𝗲. 🧪 Working with a customer like GANZIMMUN Diagnostics GmbH makes us proud and helps us understand the needs of this special industry. This way, we all can stay ahead. Check out our new customer story video that highlights the #clinical #diagnostics laboratory of GANZIMMUN, and 𝘀𝗲𝗲 𝗵𝗼𝘄 𝗼𝘂𝗿 𝗰𝘂𝘁𝘁𝗶𝗻𝗴-𝗲𝗱𝗴𝗲 𝗜𝗖𝗣-𝗠𝗦 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 𝗮𝗻𝗱 𝘁𝗵𝗲𝗶𝗿 𝗲𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 𝗮𝗻𝗱 𝗱𝗲𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗮𝗿𝗲 𝗵𝗲𝗹𝗽𝗶𝗻𝗴 𝘁𝗼 𝗽𝗿𝗼𝘃𝗶𝗱𝗲 𝗯𝗲𝘁𝘁𝗲𝗿, 𝗺𝗼𝗿𝗲 𝗮𝗰𝗰𝘂𝗿𝗮𝘁𝗲 𝗿𝗲𝘀𝘂𝗹𝘁𝘀. Many thanks to Michael Zirbes and his team! 👁🗨 Do you also rely on ICP-MS technology in the context of clinical diagnostics? Share your experiences and thoughts with us in the comments below. #healthtech #AnalytikJena

🚀 We are Hurdle 🚀 We're redefining the landscape of diagnostic testing with our comprehensive solutions tailored to power your entire diagnostic process. Hurdle is your single partner for seamlessly integrating all components necessary to launch and manage a successful diagnostic testing program. Whether you're looking to plug our solutions into your existing workflow or leverage our full suite for a bespoke end-to-end testing program, we've got you covered. 🧬 Customisable Sample Collection Kits: Our market-leading sample collection technology features custom-branded packaging to match your brand. Plus, our science and clinical teams collaborate with you to co-create biomarker panels that matter most to your patients. 🔬 Lab Testing with Accredited Labs: Connect your patients to a hand-picked network of CQC/UKAS-accredited labs across the UK & EU. Our API facilitates seamless integration, enabling a vast array of diagnostic tests. 📦 Logistics & Fulfilment Perfected: Experience industry-leading shipping times (24-48 hours) and a variety of shipping and inventory management options. Our API-driven logistics ensure seamless ordering and fulfilment, maximising return and success rates. 🔎 Cutting-edge Biomarker R&D: Accelerate your biomarker research and development with our expert team. From discovery to regulatory submissions, we're here to support every step of the biomarker R&D process, significantly speeding up development (3-10X). At Hurdle, we're not just about providing services; we're about creating partnerships that enable healthcare organisations to deliver superior diagnostic services. Let's transform the future of diagnostics together! #Hurdle #DiagnosticTesting #HealthTech #Innovation #BiomarkerResearch

Join Slalomer Kimberly Rojek at Pharma USA's "Are you really listening to your patients?" panel for a discussion on the evolution of patient engagement and finding hidden insights in patient data sets to extract true value. Let me know if I’ll see you there! #REpharmaUSA #ImWithSlalom

Join my work BFF Kimberly Rojek at Pharma USA's "Are you really listening to your patients?" panel for a discussion on the evolution of patient engagement and finding hidden insights in patient data sets to extract true value. Let me know if I’ll see you there! #REpharmaUSA #ImWithSlalom

Mara Aspinall, Partner, and David Walt, Advisor, will speak at the second annual Danaher Summit on Diagnostics on November 7. This event will focus on critical challenges that the diagnostics industry faces in unlocking the promise of precision medicine. Mara Aspinall joins Panel 2: Diagnostic Insights to Impact: The Provider at 9:45am ET, and David Walt will speak on Panel 5: Diagnostic Insights to Impact: The Innovator at 4:05pm ET. More info: https://lnkd.in/g6rQkZ6N #diagnostics #biotech #precisionmedicine 

Let’s discuss how digital innovations can lead to more accurate diagnoses, personalized treatment plans, and improved patient outcomes. Join us today for a powerhouse keynote panel at Pharma 2024 led by Johanna DeYoung! #ImWithSlalom #SlalomLifeSciences #REpharma2024

Our vision for transforming health and revolutionising outcomes for patients is a long-term one. As we celebrate 25 years of pioneering science since the merger of Astra and Zeneca. Discover how we’re looking ahead to the next wave of innovative science: https://learn.az/6040w6B1C #WhatScienceCanDo